Clinical trials
Active, not recruiting Phase 2 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2010 | 1 |
| 2014 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 4 |
| M.D. Anderson Cancer Center | 3 |
| Genmab | 2 |
| The Lymphoma Academic Research Organisation | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| AbbVie | 1 |
| Amgen | 1 |
| Andrew Yee, MD | 1 |
| Avobis Bio, LLC | 1 |
| Brown University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 48 |
| Lymphoma, Non-Hodgkin | 7 |
| Multiple Myeloma | 7 |
| Neoplasms | 6 |
| Lymphoma, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Neoplasm Metastasis | 4 |
| Burkitt Lymphoma | 3 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.